Stuart Therapeutics presented preclinical data at OIS Retina 2026 on a non-gene-specific collagen mimetic peptide that preserved retinal thickness and visual function in 2 mouse models of inherited retinal disease.
Eric Schlumpf
Advertisement
Eric Schlumpf is president and CEO of Stuart Therapeutics.
Articles by Eric Schlumpf
Advertisement
Latest Updated Articles
Advertisement
Advertisement